Sobi® (STO: SOBI) today announced that data on Aspaveli/Empaveli in C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) and NASP in uncontrolled gout ...
Research from Turner & Townsend’s 2025–2026 Data Center Construction Cost Index means companies need to pay attention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback